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Background: Antibiotics can interfere with RNA activity. 
Translation of RNA by the prokaryotic ribosome, self-splic- 
ing of group I introns, HIV replication and hammerhead 
ribozyme cleavage are inhibited by the aminoglycoside 
neomycin B.To explore the molecular basis by which small 
molecules such as antibiotics inhibit RNA function, we 
undertook an in vitro selection to obtain a variety of RNA 
molecules with the capacity to recognize neomycin. 
Results: The majority of the RNA molecules selected to 
specifically bind neomycin share a region of nucleotide 
sequence homology. From chemical probing and covariations 
among different clones we show that in all sequences this 
region folds into a hairpin structure, which from footprinting 
and partial alkaline hydrolysis experiments is shown to be the 
neomycin-binding site. Neomycin is recognized with high 
a5nity (Kd = 100 r&l) and high specificity (>lOO-fold 
higher a5nity for neomycin than for paromomycin). 
Conclusions: The fact that RNAs containing the consen- 
sus sequence, as well as sequences that display variations 
within this region, specifically recognize neomycin suggests 
that a structural motif rather than a particular nucleotide 
sequence is required for neomycin recognition. We propose 
that a hairpin stem-loop structural motif, which might 
feature a widened major groove, may be a prerequisite for 
neomycin recognition. This structural pattern can be 
extrapolated to other natural neomycin-responsive RNAs. 
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Introduction 
Aminoglycosides, as weIl as other families of antibiotics, 
are thought to disrupt several biological functions by 
directly interacting with RNA target sites. For example, 
neomycin B and related aminoglycosides such as paro- 
momycin bind to the A site of the 16s ribosomal RNA, 
which harbours the decoding function, and cause mis- 
translation, disturbing the synthesis of the encoded protein 
[l]. Many of these aminoglycoside antibiotics were also 
found to inhibit group I intron self-splicing; neomycin B 
inhibits self-splicing at the same low micromolar concen- 
tration as found for disruption of ribosome function [2,3]. 
Another RNA target affected by neomycin B is the Rev- 
responsive element (RIG), a segment in HIV-l RNA 
that binds to the Rev protein. Neomycin B binds specifi- 
cally to the same region within the RRE that is recog- 
nized by Rev and thus inhibits viral replication. This 
RNA-protein interaction is inhibited by neomycin B at a 
concentration of 1 FM [4,5]. An RNA more recently 
identified as a target for neomycin B is the hammerhead 
ribozyme. The cleavage activity of the ribozyme is 
impeded by 13.5 FM neomycin B [6]. 
These RNA targets, with the exception of the ribosomal 
RNA, can discriminate between the structural analogues 
neomycin B and paromomycin (Fig. 1). Paromomycin, 
which differs from neomycin in the substitution of a 
single amino group with a hydroxyl group, is one [6] or 
two [2,3,5] orders of magnitude weaker at eliciting an 
inhibitory response. An oligoribonucleotide analog of the 
decoding site of the 16s ribosomal RNA binds 
neomycin and paromomycin with equal affinity, 
however, mirroring the lack of discrimination of the 
ribosomal RNA [7]. 
No primary sequence homologies exist between these 
different RNAs. What, then, is being recognized by the 
antibiotics, or what is it that unites diverse RNAs as a 
common target? Changes in reactivity toward chemical 
attack in the presence of antibiotics suggested structural 
parallels between the recognition processes involved in 
decoding by the A site of the 16s ribosomal RNA [8] 
and in group I intron self-splicing [9]. Based on these 
results, a possible relationship between the mechanisms 
of splice-site selection and tRNA selection during 
decoding, which involves similar structural motifs recog- 
nized by antibiotics, has been proposed [lo]. 
An oligoribonucleotide analogue of the decoding 
region of the 16s ribosomal RNA (rRNA) was shown 
to interact with antibiotics in a manner that mimicked 
the biologically relevant conformation of this A-site 
subdomain [7]. Similarly, for the RRE it was shown that 
neomycin protects some bases from chemical modifica- 
tion that are also strongly protected by Rev [5]. These 
bases are part of the core region within the RRE. Short 
structural analogues of this region were found to bind 
selectively to Rev, suggesting that these motifs are also 
likely to be sufficient for neomycin recognition [l 11. 
Do all these different natural RNAs share common, yet 
unidentified structural motifi which make them a target for 
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Fig. 1. Structure of the aminoglycoside antibiotics neomycin (R1= 
-NH,) and paromomycin (R1= -OH). 
recognition by neomycin B? Using in vitro selection, we set 
out to obtain a series of short RNA sequences from a ran- 
domized pool that bind to neomycin B and allow a com- 
parison with the natural neomycin-responsive RNAs. In 
vitro selection or SELEX [12-141 allows the screening of a 
large number of individual nucleic acid molecules for dif- 
ferent fimctionalities (reviewed in [15-l 81). Our aim was 
to isolate and characterize small RNA molecules which 
could interact with antibiotics specifically and with high 
affinity in solution. We sought to isolate recurring motifs 
recognized by antibiotics, in order to understand the 
minimal requirements of antibiotic-RNA interactions. 
Such information can then be used to help decipher 
known biological examples, which are often larger and less 
amenable to study Characterization of these individual 
molecules revealed a novel motif that recognizes neomycin 
specifically and with high afhnity. 
Results 
Novel neomycin-binding RNAs isolated by in vitro selection 
RNA molecules having specific affinity for neomycin 
(Fig. 1) were isolated from a pool of RNA molecules 
with a random region of 74 nucleotides flanked by 
defined regions which enabled primer binding (total 
length 111 nucleotides). Initially the complexity of the 
pool was -1015 different molecules.The pool was applied 
to a neomycin-derivatized agarose affinity column 
(neomycin concentration -1 mM) followed by a buffer 
wash to remove non-specifically or weakly binding 
RNAs. Neomycin-binding RNAs were affinity-eluted 
with buffer containing 2.5 mM neomycin. To minimize 
enrichment of RNAs whose binding to neomycin 
involved contribution from the agarose matrix, the RNA 
molecules were affinity-eluted with free antibiotic in 
solution to guarantee a specific recognition of neomycin. 
The progress of the selection, as defined by the enrich- 
ment for neomycin-specific sequences, was monitored by 
determining the percentage of the input RNA eluted 
from the neomycin-agarose with free antibiotic. Table 1 
summarizes the evolution of the neomycin selection. 
Over the course of selection the stringency was increased 
by increasing the number of buffer washes prior to affin- 
ity elution with neomycin. Over the first three rounds of 
selection, as the number of buffer washes was progres- 
sively increased from 5 to 30 and then further to 50, the 
corresponding percentage of RNA eluted was selectively 
decreased from 12 % to 5.1 % and then to 0.22 %. 
During cycles three to six, where the number of buffer 
washes was held constant at 50, a 13-fold increase in the 
enrichment was seen from 0.22 % to 2.9 %. A dramatic 
increase was seen at cycle seven and a significant further 
increase at cycle eight.The selection was stopped when 
the elutable percentage of the neomycin-binding RNAs 
reached 55 %. Approximately lo3 RNA molecules 
capable of binding neomycin were selected from the 
original pool of 1015, suggesting that there are many pos- 
sible sequence solutions to neomycin recognition. 
Sequence and structure analyses of individual 
neomycin-specific RNAs 
To investigate the individual RNA species comprising 
the pool at the eighth selection cycle, the pool was 
cloned and 21 clones were sequenced. The random 
region sequences are shown in Fig. 2a. Despite the 
high specificity for neomycin, there was significant 
sequence variation among different clones. However, 
-50 % of the RNAs contained a conserved 13- 
nucleotide consensus sequence, GGGCGNR- 
NAGUUU (where N is any nucleotide and R is a 
purine). Regions upstream and downstream of this 
consensus sequence can fold to form Watson-Crick 
base pairs. Folding of the individual full-length 
sequences having this motif with the Zuker program 
[19] presents this region of primary homology in a 
hairpin stem-loop structure. The stem varies both in 
sequence and in length and contains a conserved 
three-base-pair stretch of G:U wobble pairs. The loop 
sequences share the consensus GNRNA. The constant 
primer binding regions were not used in the structure 
prediction of this hairpin motif. 
Table 1. Progressive enrichment of neomycin-specific RNAs. 
Cycle Buffer Affinity 
washesa washes 
% Input 
elutedb 
1 5 2 12 
2 30 2 5.1 
3 50 2 0.22 
4 50 2 0.40 
5 50 2 1.6 
6 50 2 2.9 
7 30 2 24 
8 30 2 55 
The table summarizes the progressive stringency of selection. 
=Number of buffer washes before the neomycin-affinity wash. 
bRNA affinity-eluted with neomycin expressed as a percentage 
of the total RNA input. 
Cd 5'1 51 3' 
CGGUGAA AUCAUUAGUC UCUAAGAGUC UAU 
AGCAUGA ACUGUGAUCG UCGAUGCACU A 
UGA UACUACACAU CGUGUGAAGU GUUUUAGAAG GAUUGGCUAG U 
UCU GCUUUC 
GUCUGGAC AAGGAAUAUC GUUC 
neo9 CUUUGGGGUU GUUUAAAAUA UCAAGUUUCG UGU GCG ACUUGAUGUU UGAACAACCC GAU 
neoll CCUGUUGGAA CUAAAUU CAC CAGUAGUCGA UUGUUGUCCA CUGUCG 
UUGUUACU GGGGUCUGAA AUCCC 
GCAGCCGU UCGUGAUCCC ACUU 
UUUUCUCG AUUUUAAAUC A 
CGAUGCAA AACUUCUCGA GACG 
CAGAGAAC UAGUUUCGGA GUC 
ACGUUCCU CCUGCGGUUU GUUC 
CACACUAG UAUAUCCUAG UGUCG 
neo56 AAUACGGGGA GAUCGGUAGA GAU GUUCCC GGUAUUGUGG AGCCAUUGAU GCUA 
neo59 UUACAUGGCG AGUAUAUCUA ACACUGACAU UCCACGGAUU GAGUGGAGGU AUAUAAUAUU ACUUUAGCUG UGUC 
neo60 GGCUAUGCCA ACUUUUAAGG G A GCCAUGCCUG GACAGGUCAC CAAGAGGCCU UUCUAG 
neo61 CACUGAGCGU AGAACUGUGU A A GCUUUCGAAA GUCAUGUCGC UGUGGAGCUA AGUU 
neo63 AUCUGAUAUG CUUGAAGUCU U C AAAACCAGUG UAAGCAUUCA GAUGCAUUGU UCC 
neo66 GAUACAUUGU CCGAUCUAAG U G UCAAGGUCAU UCCUUUAAAU UUCCUUGCAC U 
neo68 CACGCGCAGA UAGAGAGCGG CUAUAUCCUU CCGAAAUGUU GGGGCACCGU UCUCAAAUGG CGUGUGUUCU UGUG 
(b) 
neo2/45/51/61 5'-GGGCGAAAA@JJ!J-3' 
neo63 5'- 
neol6ll9 5'- 
neo44 5'- 
neo9lll 5'- 
neo49 5'- 
neo3:5'- 
neo5:5'- 
Fig. 2. Nucleotide sequences of neomycin-agarose selected clones. (a) Sequences of 21 individual clones from the pool after the 
eighth cycle of the neomycin selection. The clone number is shown at the left-hand side. The sequences shown comprise only the 74 
nucleotides that were random at the beginning of the selection. Nucleotides matching the 13-nucleotide consensus sequence and 
closely matching sequences are highlighted in green. (b) Consensus sequence of the motif recognized by neomycin. The most con- 
served region (13 nucleotides). Highlighted in orange are nucleotides differing from the most commonly occurring sequence, S’-GCGC- 
GAAAACUUU-3’. Of the consensus variations, the upper group comprises those sequences with minor deviations from this consensus, 
whereas the lower pair show more extensive divergence. The underlined nucleotides indicate putative base-pairing partners. 
Other sequences, which might initially appear less 
closely related to this conserved motif due to significant 
sequence variation, are nonetheless intriguing for two 
reasons: (i) the clones still have the potential to form the 
proposed hairpin structure containing a five-membered 
loop, and (ii) the positions of the variations within this 
hairpin structure (Fig. 2b). Notable examples include 
clones neo3 and neo5. For clone neo5, significant vari- 
ability is seen in the stem.The resulting hairpin struc- 
ture has two of the G:U wobble base pairs replaced with 
G:C base pairs. Neo3 also shows sequence variations in 
both the loop and the stems; the hairpin structure 
nonetheless contains three G:U pairs and a G:C pair 
closing the loop.The presence of clones neo3 and neo5 
in the selected sequences gives weight to this novel 
hairpin stem-loop structure. To test whether these 
sequence covariations indeed reflect our proposed sec- 
ondary structure model, we analyzed a series of the 
selected sequences by chemical modification. 
Footprinting the sites of interaction of neomycin with 
selected RNAs 
We also used a second approach to localize the region of 
neomycin interaction within individual selected clones. 
Base-specific chemical probes were used (i) to investi- 
gate the solution structure of the RNAs and (ii) to 
identify the neomycin binding site(s). RNA from repre- 
sentative clones of different sequence classes (see Fig. 2b) 
were incubated in the presence or absence of neomycin 
or paromomycin under the same conditions used in the 
selection procedure. Dimethyl sulfate (DMS), kethoxal 
or CMCT (l-cyclohexyl-3-(2-morpholinoethyl)-car- 
bodiimide metho-p-toluene sulfonate) were subse- 
quently added to modify bases specifically at accessible 
positions, as described previously 19,201. DMS methy- 
lates adenine at position Nl, cytosine at N3 and also the 
N7 position of guanine, kethoxal modifies the Nl and 
N2 positions of guanine and CMCT modifies the Nl 
and N3 of guanine and uracil, respectively. Positions of 
modification were determined by reverse transcription 
of probed RNAs. A typical autoradiograph showing the 
modification pattern of clone neo5 is shown in Figure 
3a. 
In the presence of 1 PM neomycin, several bases were 
clearly protected against modification by DMS or 
kethoxal. It is remarkable that these bases all fall into or 
around the conserved sequence motif described above. 
Little protection of the same bases was observed using a 
loo-fold higher concentration of the closely related 
antibiotic paromomycin. The kethoxal modification 
pattern of clone neo16 is shown in Figure 3b. Here, a 
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Fig. 3. Probing the structure of selected antibiotic binding RNAs in the presence of neomycin. (a) Modification pattern of clone neo5. 
The neomycin concentrations were 1 and 10 pM; the paromomycin concentration was 100 pM. Dots indicate protection at adenines 
and cytidines; stars and arrows indicate protection at guanine Nl/N2 or N7 positions, respectively. K: control (no modification), - : no 
antibiotic, KE: kethoxal, DMSIGN7: detection of modification at GN7, A and G: dideoxy sequencing lanes. (b) Kethoxal modification 
pattern of clone neo16. Same abbreviations as in (a). The neomycin concentration was 1 pM and paromomycin was 100 uM. (c) 
Secondary structure representation of regions showing neomycin footprint from the clones tested in chemical probing experiments. 
Positions of protection or enhancement by neomycin at 1 uM are indicated. Large symbols represent complete protection, small 
symbols, weak protection. 0 : protection by neomycin at Watson-Crick positions; A : enhancement by neomycin at Watson-Crick 
positions; 0 : protection by neomycin at G-N7 positions. 
similar pattern is observed: complete protection of an 
otherwize highly modified guanine in the presence of 
1 p,M neomycin (in addition to other bases in the 
hairpin motif, data not shown), and less protection using 
100 I.LM paromomycin. This protected guanine lies in 
the middle of the conserved five-membered loop 
described above (Fig. 3~). 
Two more clones from other classes of selected RNAs 
(neo9 and neo61) were tested for binding of antibiotics 
by chemical probing. Again, the neomycin footprint was 
located solely within the conserved motif with at least 
loo-fold discrimination compared to paromomycin (data 
not shown). The secondary structure and the neomycin 
protection patterns of the four clones are summarized in 
Figure 3c. It is interesting to note that part of the foot- 
print pattern was always located at the third and fourth 
nucleotides of the loop, independent of which nucleotide 
was present at this position. 
The principal stem-loop structure suggested by sequence 
comparison was corroborated by the modification 
pattern of the RNAs in the absence of antibiotics. In 
addition, the chemical probing analysis suggests that the 
stem contains bulged nucleotides, some of which 
become strongly protected against modification by 
neomycin binding. 
Finally, the clone neo3 was tested because of the strong 
divergence in the loop region (three uridines) from the 
consensus sequence. Because of strong stops of the 
reverse-transcribed RNA in the loop region we were 
unable to inspect this part of the motif (by CMCT 
modification). However, a strong neomycin-induced 
RNA reCOgnltlOn Or neOmyCln VValll5 el dl. 39, 
footprint of a bulged cytidine seven nucleotides 
upstream of the loop suggests that the binding region 
for neomycin is indeed localized in this region of the 
sequence (compare Fig. 2). 
The strength of neomycin binding to the neo5 RNA was 
determined by titration of neomycin before DMS modifi- 
cation.The strength of protection of the two consecutive 
adenines in the loop region at neomycin concentrations 
between 1 I.LM and 50 nM was measured by quantifying 
the radioactivity in the respective bands with a 
Phosphorimager. In Figure 4, showing the graph of peak 
intensity versus neomycin concentration, it can be seen 
that the peak does not further level off at concentrations 
higher than 0.5 ~.LM neomycin, where it reaches satura- 
tion. Samples showing a linear relationship between peak 
intensity and neomycin concentration were used for a 
regression analysis to estimate the dissociation constant 
(see inset Fig. 4).The K, of neomycin to clone neo5 was 
determined to be 115 & 25 nM. From visual inspection of 
autoradiographs from other chemical modification experi- 
ments we estimated the K, of neomycin to be in the same 
range as that for the other footprinted clones. 
localization of the minimum neomycin-interaction site 
As a first step towards ascertaining whether this putative 
motif was sufficient for neomycin binding in solution, a 
shortened version of one of the clones (neobl) was 
designed, taking into consideration the semi-conserved 
consensus sequence, to make a DNA template of reduced 
size (27 nucleotides in the ‘random positions’ compared 
with the original 74, giving an overall RNA length of 
64 nucleotides including primer sites). The RNA result- 
ing from this template is referred to as ‘neocon’.The foot- 
printing data for this smaller RNA reflected the pattern 
observed for the parent sequence neobl (Fig. 3c) and 
confirmed the stem-loop structure. Furthermore, this 
Figure 4. Quantification of protection against chemical modifica- 
tion of two consecutive adenines in the neo5 loop (see Figs 3a,c) 
by neomycin. The peak intensity of the two adenines (mean 
value with error bars) by DMS modification reaches background 
at 0.5 )LM neomycin. The inset shows the same graph with an 
expanded X-axis and a linear regression reaching the saturation 
level (dotted line) at -0.23 ~.LM (see arrow). The K, of neomycin 
binding to neo5 was inferred to be 115 f 25 nM. 
sequence had binding and elution characteristics which 
compared favourably with the parent sequence and other 
full-length neomycin-binding clones (data not shown). 
To localize the antibiotic-recognition site within these 
selected sequences by an independent approach in addi- 
tion to footprinting, and to determine whether the con- 
sensus region and resulting putative stem-loop structure 
were solely responsible for neomycin binding, we sub- 
jected end-labelled RNA from the four clones tested in 
the footprinting approach (neocon, neo5, neo9 and 
neo16) to partial alkaline hydrolysis. The idea was to 
generate RNA pools of the four individual sequences 
which encompassed all possible lengths between one 
nucleotide and the full-length RNA. These pools were 
tested for their abilities to bind to the neomycin column 
and to elute specifically with neomycin.The minimum 
length of RNA which is required for binding and 
elution by neomycin could thus be determined. 
The 5’ or 3’ end-labelled, partially hydrolyzed pools from 
individual clones were applied to the neomycin-agarose 
column under the same conditions as in the initial 
sequence-selection procedure. After the buffer wash, the 
RNA was affinity-eluted with neomycin, precipitated 
and subjected to polyacrylamide gel electrophoresis, in 
parallel with non-selected, partially hydrolyzed RNA of 
the same pool and T,-digested RNA, for sequence 
determination.As can be seen in Figure 5a,b (for either 
5’-labelled or 3’-labelled RNA), there was always a 
certain sub-population of small RNAs that was unable to 
bind. By using either 5’ or 3’ end-labelled RNA, the 
nucleotides that can be removed from 3’ or 5’ ends of the 
RNA, respectively, without affecting binding can be 
determined to single-nucleotide resolution. 
A graphical presentation of the nucleotides that could 
not be removed without affecting neomycin recognition 
and elution is shown in Figure 5c. The region that was 
found to be required for neomycin recognition in these 
experiments was identical to the region identified by 
sequence comparison and footprinting of the full-length 
RNAs. Taken together, these results suggest that this 
hairpin motif is sufficient for neomycin recognition. The 
total length necessary for binding of the individual 
clones was between 20 and 22 nucleotides, with the 
exception of clone neo9 which required a length of 36 
nucleotides. Interestingly, some RNAs longer than the 
minimal ones seem to be counter-selected, as can be seen 
from the gaps in the lanes for the selected RNAs. It is 
possible that certain free ends might interfere with the 
crucial stem-loop structure, for example by base-pairing 
to the loop. Further characterization, including NMR 
analysis (M. Kochoyan, personal communication) of 
these short RNAs are currently under way. 
Specific recognition of neomycin 
To show that the affinity of the in vitro selected RNA 
molecules was specific for neomycin we tested the 
ability of individual clones to bind neomycin and a 
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(d neocon 
(N),&UGC~GUGUAGGGCGAAAAGUUUUb,bAU(N~, 
‘5:------- 
l a . . . . .  
3 
neo5 
(N),&$CyGCAGUCCGAAAAGGGCCA+GU(N),, 
--__. *-...-. 
5 3 
neo9 
(N),,AAU~-~AAGUUUCGUGUGGGCGCACAGUUUGGCGACUUGA~UUU(Nh, . . . . . _ _ 
5 3 
neol6 
(N)30ACGU~CCUGGGCGAGAAGUUUAG(GAU(N)~~ _-- -___.. . . ..- 
5 3’ 
Fig. 5. Determination of length requirement for neomycin binding. Autoradiograph showing (a) 5’.labelled, or (b) 3’-labelled, partially- 
hydrolyzed RNAs from individual clones which were capable of binding to and eluting from neomycin-agarose (lanes labelled as ‘sel’). 
Unselected (‘tot’) and Tl -digested (non-hydrolyzed, lanes labelled as ‘Tl ‘) RNAs were run in parallel. An arrow indicates the position from 
which further removal of nucleotides prevented neomycin recognition. (c) Summary diagram of the minimum neomycin-binding 
sequences as determined by selection of partially hydrolyzed RNAs. The loop region is shown in italics. Dotted arrows indicate 
nucleotides that can be removed while retaining neomycin-binding capacity. 
closely related analogue, paromomycin (Fig. 1, R,= 
-NH, and -OH, respectively) since this conservative 
structural substitution results in a dramatic difference in 
activity [3,5,6]. 
Individual clones were applied to the neomycin-agarose 
column and the RNA was affinity-eluted with antibi- 
otic.Thus a competition exists between antibiotic (either 
neomycin or paromomycin) in solution and immobilized 
neomycin on the column. The ability of neomycin or 
paromomycin to affinity-elute RNA was compared in 
two ways: the percentages of RNA eluted were com- 
pared for a given antibiotic concentration (see Table 2), 
and the antibiotic concentrations required to elute a 
given percentage of RNA were compared (data not 
shown). Although these structural analogues are 
extremely similar, a strong preference for neomycin 
over paromomycin can be seen. This discriminatory 
RNA recognition of neomycin Wallis et al. 54Y 
Table 2. Antibiotic affinity and homologue discrimination for 
clone neo5. 
Antibiotic 
concentration 
Neomycina Paromomycina 
250 FM 54 “/cl 0.6 % 
25 /.LM 48 % ND 
Effect of varying the concentration or type of antibiotic on 
elution of RNA from a neomycin-agarose column. 
“Output counts per minute (cpm) as a percentage of the input 
cpm for two affinity washes. ND, not determined. 
behaviour, which was not selected for, was also seen in 
the chemical modification analyses in which paro- 
momycin protected the selected RNAs only at a con- 
centration 1 O&fold higher than neomycin. 
Magnesium dependence and metal specificity analyses 
For neomycin, the sensitivity of group I intron self-splic- 
ing to antibiotic was shown to increase as the concentra- 
tion of Mg2’ Ions decreased [21]. A similar competitive 
effect of Mg” on neomycin inhibition was found for 
the hammerhead ribozyme [22]. These observations are 
consistent with the fact that at neutral pH the antibiotic 
is positively charged [23]. We investigated the possible 
electrostatic component of this interaction by monitor- 
ing the ability of RNAs to recognize neomycin under 
varying Mg’+ ion concentrations and in the presence of 
different divalent ions. 
Individual RNAs were applied to a neomycin-agarose 
column, washed with buffer to remove RNAs that did 
not specifically bind to the antibiotic and affinity-eluted 
with neomycin in the same buffer.The buffers differed 
only in the concentration of MgCl, in the range from 
O-20 mM. Figure 6, which shows the effect of varying 
the concentration of divalent magnesium ions on the 
specific elution of RNA with neomycin, depicts the 
cumulative output RNA expressed as a percentage of 
Fig. 6. Magnesium concentration 
(O-20 mM Mg2+) dependence elution 
profile for neo5. Cumulative output 
cpm are expressed as a percentage of 
the input cpm. Internally labelled RNA 
was specifically affinity-eluted with 
neomycin (2.5 mM, fractions 1 l-l 5) 
from neomycin-agarose. 
the input RNA plotted as a function of the fraction 
number for the clone neo5. This clearly demonstrates 
the effect on both RNA binding to neomycin immobi- 
lized on the agarose as well as free in solution. The 
elution profiles from fractions one to ten (buffer wash) 
represent the effect of Mg” ions on the binding of 
RNA to the neomycin coupled to the agarose, whereas 
in fractions 11 to 15 (affinity wash) the effect is on the 
ability of the RNA to recognize free neomycin in solu- 
tion. It can be seen that increasing the concentration of 
Mg2+ ions in the buffer decreases the affinity of the 
RNA for the agarose-bound neomycin. The ability of 
neomycin to elute bound RNA from the column shows 
a maximum at -5-10 mM Mg”. In the absence of 
divalent Mg ions some RNA can still be eluted with 
neomycin.The elution profiles of other clones (data not 
shown) show a similar response to the effect of varying 
Mg2+ concentration on binding to neomycin on the 
column. The optimum concentration for solution 
binding of neomycin, however, varies with different 
sequences. These results indicate either that Mg’+ com- 
petes with neomycin in the interaction with RNA, or 
that at higher magnesium concentrations a different 
RNA structure is formed which does not allow 
neomycin recognition. Note that the original selection 
conditions included 5 mM MgCl,. 
The hypothesis that neomycin and magnesium directly 
compete for binding to RNA was investigated by a foot- 
printing experiment with the neo5 clone in the absence 
of magnesium ions.The modification pattern as well as 
the neomycin protections were found to be the same as 
in the experiment including 5 mM Mg*+, indicating that 
the structure formation does not depend on Mg’+ ions. 
If magnesium competes with neomycin for the RNA, 
we would expect a much stronger footprint in the 
absence than in the presence of magnesium ions. This 
was not the case (data not shown). A more detailed 
quantitative analysis is required to address this question; it 
seems, however, that the interaction of neomycin with 
0 
0 10 
Fraction number 
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our RNAs cannot solely be explained by a competitive 
electrostatic interaction. 
Finally, the effect of varying the type of divalent metal 
ion present in solution (while maintaining the concen- 
tration at 5 mM) upon the ability of individual RNA 
molecules to bind neomycin was also investigated (data 
not shown). M$+ and Ca2’ ions show very similar pro- 
files. Both types of ions are able to mediate neomycin 
binding on the column and in solution. Mn2+ ions, 
however, are not; in the presence of manganese the 
RNA appears to be unable to assume a structure able to 
recognize agarose-bound neomycin. 
Discussion 
Eight rounds of in vitro selection allowed the enrichment 
of an RNA pool, originally containing -lOI different 
molecules, for RNAs specifically binding neomycin. 
Although there is considerable variability at the level of 
primary structure, more than 50 o/o of the sequences share 
a similar secondary structure, namely a hairpin whose 
stem is ‘loosened’ by the presence of G:U base pairs and 
which includes an asymmetric bulge. Chemical modifi- 
cation and partial alkaline hydrolysis analyses confirmed 
this structure and defined this novel stem-loop motif as 
the neomycin B binding site. From chemical modifica- 
tion analysis it was found that other sequences from our 
selection which differed from the consensus sequence 
also harboured this motif, and that variations in sequence 
are tolerated for neomycin recognition. It is plausible that 
in those sequences which lack the consensus sequence 
(see Fig. 2a) a similar motif is present but currently 
escapes our attention. Neomycin binds with high affinity 
(Kd = 100 nM) and high specificity (affinity for 
neomycin is >lOO-fold higher than for paromomycin). 
The neomycin-recognition properties of selected indi- 
vidual sequences were addressed with respect to various 
metal ion conditions.The optimum Mg2’ concentration 
for neomycin binding in solution varied depending on 
the individual RNA. Furthermore, Ca2+ ions were also 
able to substitute for M$+. 
RNA structures recognized by aminoglycoside antibiotics 
Recently, in vitro selected RNAs with affinity for other 
aminoglycoside antibiotics, kanamycin A, lividomycin 
[24] and tobramycin [25], have been selected from 
random-sequence pools. Unlike the neomycin selection, 
the kanamycin A and lividomycin selections did not result 
in the isolation of any predominant sequence or structural 
feature. Similarly, the selection of tobramycin-binding 
RNAs under conditions of low stringency revealed no 
obvious consensus sequence. At high stringencies, 
however, two partially homologous consensus sequences 
were observed which are predicted to form stem-loop 
regions, possibly presenting a bulge. The binding sites of 
the antibiotics were not further determined. 
The fact that our in vitro selected RNAs specifically 
recognize neomycin despite consensus-sequence varia- 
tions, taken together with the observation that natural 
neomycin-responsive RNAs contain no sequence 
homology, leads us to conclude that it is predominantly 
structure, or molecular shape, that is crucial for neomycin 
recognition. Perhaps the most noticeable feature of our 
selected neomycin-binding RNA motif is the adjacent 
G:U wobble base pairs and the presence of an internal 
bulge in the majority of the selected sequences. An X- 
ray structural analysis of an RNA double helix [26] iden- 
tified a widened major groove originating from 
alternating G:U and C:U base pairs contained in this 
helix. A very similar structural motif was identified in 
one of the natural neomycin-responsive RNA 
sequences, the core region of the RRE [4,3 1,271. This 
region consists of at least two non-canonical 
Watson-Crick base pairs which lead to a widening of 
the major groove in the otherwise regular A-type helix 
of the flanking regions. Just like our selected motifs, the 
RRE core also contains internal bulges which are 
important for Rev and possibly also for neomycin 
binding. Perhaps this motif can be extrapolated to the 
decoding site of the 16s rRNA since it also presents an 
asymmetric bulged helix [28]. Several other examples of 
distorted or irregular helices featuring widened major 
grooves have been reported ([29] and references therein). 
The irregular structure of the eukaryotic 5s rRNA loop 
E results from uncommon base pairs such as G:A and the 
reverse-Hoogsteen configuration of A:U 130). The 
sarciniricin loop structure is also stabilized by several 
non-Watson-Crick pairings [31]. 
From these analyses we conclude that the G:U pairs in 
our selected motifs, in addition to an asymmetric bulge, 
are likely to lead to a widened major groove formed by 
the helix in the hairpin. Furthermore, the protection 
pattern at G-N7 positions (positions that are located in 
the major groove of an A-type helix) can be found in 
all RNA molecules sensitive to neomycin B that have 
been footprinted [5,7-91. One explanation for the G- 
N7 footprint is that it results from a direct contact with 
neoymcin which might require a widened major 
groove and would explain why the ‘loosened stem’ of 
the consensus motif is an important feature of the 
sequences isolated from our neomycin selection. This 
recognition element, however, may also include an as 
yet undefined sequence component since the majority 
of the selected sequences share a 13-nucleotide consen- 
sus region. Other in vitro selections show that many 
sequence solutions to aminoglycoside antibiotic 
binding appear to exist [24,25]. Our studies suggest, 
however, that a crucial factor for antibiotic recognition 
lies at the structural level.This may also hold true for 
these other selected sequences. 
We have gained an insight into the RNA structural 
requirements for neomycin recognition which might be 
common to other neomycin-targeted RNAs. Many 
RNAs would fit these recognition criteria, which require 
further refinement. Additionally, for the naturally occur- 
ring neomycin-responsive RNAs a further constraint on 
RNA structure may be imposed at the functional level. 
Significance 
RNA molecules of diverse sequence and function 
can be inhibited by a single type of antibiotic 
molecule. To explore the molecular basis for the 
recognition of small molecules by RNAs, we 
undertook an in vitro selection to obtain a variety 
of RNA molecules with the capacity to recognize 
neomycin specifically and with high afi?nity. 
These RNAs present a consensus sequence which 
folds into a hairpin motif which includes a 
GNRNA loop, the stem of which might feature a 
widened major groove due to the presence of 
G:U base pairs and an asymmetric bulge. Three 
independent lines of evidence, sequence compari- 
son, footprinting and partial alkaline hydrolysis 
experiments, identified this novel stem-loop 
motif as the neomycin-binding site. This struc- 
ture, while novel, nonetheless contains features 
which we propose to be common to neomycin 
recognition since structural similarities can be 
identified in other neomycin targets. Thus in vitro 
selection has allowed us to gain an understanding 
of the minimal requirements of antibiotic-RNA 
interactions and to identify a structural motif that 
may be common to natural neomycin-responsive 
RNA targets. 
Materials and methods 
Materials 
Neomycin sulphate (90-95 % neomycin B, balance neomycin 
C, a stereoisomer at the C, position of the B ring) and epoxy- 
activated Sepharose were purchased from the Sigma Chemical 
Company and Pharmacia Biotech, respectively. Hydrated metal 
chlorides were from Merck. 
In vitro selection: general molecular biology and random 
pool construction 
Reverse transcription, polymerase chain reaction amplification 
and transcription, cloning (pGem3Z vector, Promega) and 
sequencing were performed as reported elsewhere [32].The 
original random-sequence RNA pool was synthesized as 
described previously [32]. For the first round of selection, 
approximately four pool equivalents were used. 
Neomycin affinity chromatography selection procedure 
The selection was performed with modifications to a previ- 
ously described protocol [32]. 32P-labelled RNA (16.6 nmol 
in the initial selection) in selection buffer (5 mM MgCl,, 
50 mM Tris-HCl pH 7.6, 250 mM NaCl) was applied to a 
1 ml neomycin-agarose column. The agarose was derivatized 
following the manufacturer’s recommended procedures. 
Neomycin was covalently coupled at -1 mM, assuming a 
coupling efficiency of 50 O/o. The neomycin column was 
washed with selection buffer (buffer wash) before specifically 
bound RNAs were eluted by the addition of two column 
volumes of 2.5 mM neomycin in selection buffer (affinity 
wash). In the initial selection round the RNA was end- 
labelled, thereafter it was internally labelled. To minimize 
enrichment of RNA molecules not specifically recognising 
neomycin but binding also the agarose matrix, three precau- 
tions were taken. First, 1 mole-equivalent of unlabelled 
tRNA (from brewer’s yeast, Boehringer Mannheim GmbH) 
was added to the random sequence labelled RNA for the 
affinity-chromatography selection, and second, before the 
neomycin-column the RNA was passed over a 
glycine-agarose (0.5 ml, derivatized at 3 mM) precolumn 
which was washed, with one column volume only, directly 
onto the neomycin-affinity column. Third, the RNAs were 
eluted with free neomycin in solution. It is anticipated that 
the immobilized neomycin will exist as a heterogeneous 
population since this aminoglycoside antibiotic presents 
several functional groups with the potential to form a cova- 
lent linkage to the agarose matrix. However, specific elution 
of the RNA molecules with neomycin in solution ought to 
minimize the possibility of multiple recognition of this same 
molecule bound to the column. The eluted neomycin-spe- 
cific RNA was ethanol-precipitated using glycogen as a 
carrier, converted to DNA and amplified by PCR, PAGE- 
purified and transcribed. This set of procedures constituted 
one selection cycle and the resulting purified RNA was the 
input for the subsequent round of selection. 
Antibiotic affinity and discrimination, and metal 
dependence and selectivity 
Tests for antibiotic affinity and discrimination, or metal 
dependence and selectivity were carried out using on 
average 0.1-l pg of 32P internally labelled RNA.The RNA 
was applied to a 1 ml neomycin-agarose column (derivatized 
at -lmM), washed with selection buffer and specifically 
eluted with antibiotic in this buffer, as described above for 
the selection procedure. For the antibiotic-affinity experi- 
ments the buffer used was the standard selection buffer 
(5 mM MgCl,, 50 mM Tris-HCl pH 7.6, 250 mM NaCl); 
the concentration of neomycin in the buffer varied only 
during affinity-elution, generally between 2.5 mM and 
25 FM, as indicated in the text and in Table 2.The selection 
buffer was also employed for the metal dependence elution 
experiments, except that the Mg2+ concentration was varied 
over the range O-20 mM (see Fig. 6).The concentration of 
neomycin in the affinity wash was always 2.5 mM under 
conditions of varying metal. The metal selectivity experi- 
ments similarly used the selection buffer except that the Mg 
was substituted with 5 mM of either Ca or Mn. Note that in 
addition the Mn-selection buffer contained 2.5 mM dithio- 
threitol. Fractions (one column volume) were quantitated by 
Cerenkov scintillation counting. 
Selection of partially hydrolyzed RNAs 
Individual clones (neocon, neo5, neo9 and neo16) were 32P 5’ 
or 3’ end-labelled and subjected to partial alkaline hydrolysis. 
End-labelling was performed as described previously by the 
manufacturers of T4 RNA ligase (Boehringer Mannheim 
GmbH) and PNKinase (New England Biolabs). Alkaline 
hydrolysis was initiated by addition of the same volume of 
50 mM NaHC03 (pH 8.5) to end-labelled RNA (in water) 
in the presence of 1.5 pg tRNA as carrier. Samples were 
incubated for 10 min at 90 “C and subsequently precipitated. 
The RNA was applied to neomycin-agarose (I mM, 1 ml) 
and affinity-eluted with neomycin (0.25 mM in selection 
buffer, five column volumes) after removal of non-specific 
binding molecules with buffer (ten column volumes) The first 
and second neomycin affinity washes corresponded to 
85-95 % of the elutable RNA at this neomycin concentra- 
tion, hence only these two fractions were precipitated. Thus 
we obtained partially hydrolyzed RNA still capable of 
neomycin recognition. These molecules, sub-populations of 
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four full-length clones, were analyzed by electrophoresis on an 
8 %I polyacrylamide gel. 
Chemical modification experiments 
If1 vitro transcribed and gel-eluted RNA was activated in 2x 
binding buffer for 1.5 min at 5h “C, and subsequently trans- 
ferred to 20 “C. lx binding buffer (5 mM MgCl,, 200 mM 
NH,CI, 80 mM K-cacodylate pH 7.4) and incubation temper- 
ature (20 “C) were chosen to be similar to selection conditions. 
RNA (-1-5 pmole per sample) was preincubated with anti- 
biotic for 15 min at 20 “C in lx binding buffer in a 50 ~1 
probing volume. Samples were transferred to ice and the modi- 
fication agent was added and incubated for 10-15 min at 
20 “C. For DMS modification, 1 ~1 1:lO (in ethanol) diluted 
DMS was added, for kethoxal, 1 p+l of 1:5 diluted kethoxal stock 
solution (37 mg m-‘) was used, and for CMCT (l-cyclo- 
hexyl-3-(2-morpholinoethyl)-carbodiimide metho-p-toluene 
sulfonate) modification, 10 FL1 of a 34 mg ml-’ solution (in 
binding buffer) was added in a 50 ~1 total probing volume. 
After precipitation (in the presence of 10 pg glycogen), samples 
were dissolved in H,O (or 25 mM K-borate pH 7.0 for 
kcthoxal modified samples) and stored at -20 “C. Detection of 
modified positions by primer extension and polyacrylamide gel 
clectrophoresis was performed as described previously [9,20]. 
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